Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.
Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A. Khalifa J, et al. Among authors: catalaa i. Eur Radiol. 2016 Nov;26(11):4194-4203. doi: 10.1007/s00330-016-4234-5. Epub 2016 Feb 2. Eur Radiol. 2016. PMID: 26843012 Clinical Trial.
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC. Laprie A, et al. Among authors: catalaa i. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):773-81. doi: 10.1016/j.ijrobp.2007.10.039. Int J Radiat Oncol Biol Phys. 2008. PMID: 18262090 Clinical Trial.
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A, Ken S, Filleron T, Rowland B, Laruelo A, Catalaa I, Lubrano V, Celsis P, Berry I, Mogicato G, Cohen-Jonathan Moyal E, Laprie A. Deviers A, et al. Among authors: catalaa i. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):385-93. doi: 10.1016/j.ijrobp.2014.06.009. Epub 2014 Aug 4. Int J Radiat Oncol Biol Phys. 2014. PMID: 25104068 Clinical Trial.
Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?
Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A. Khalifa J, et al. Among authors: catalaa i. J Neurooncol. 2016 Oct;130(1):181-192. doi: 10.1007/s11060-016-2232-8. Epub 2016 Aug 8. J Neurooncol. 2016. PMID: 27502603
39 results